MAPT

Age at Symptom Onset and Death and Disease Duration in Genetic Frontotemporal Dementia - An International Retrospective Cohort Study

Our study showed that age at symptom onset and at death of people with genetic frontotemporal dementia is influenced by genetic group and, particularly for MAPT mutations, by the specific mutation carried and by family membership.